$3250 | Single User
$4650 | Site License
$5650 | Global License

Point of Care (POC) Lipid Diagnostics Market, By Application (Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease), By Instrument (Roche Cobas b 101, Abaxis Piccolo Xpress, Roche Reflotron, Alere Cholestech LDX, and others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast
[Lowest Price Guaranteed: $3,250]

Published by AnalystView: 01 Jul 2020 | 270582 | In Stock
Related Topics: COVID , Diabetes , Roche

Introduction

REPORT HIGHLIGHT

The Point of Care Lipid Diagnostics market is estimated to represent a global market of USD 210.5 million by 2019 with growth rate of 3.3%.

Market Dynamics

Point of care lipid testing is the testing of lipid content in order to improve the risk of cardiovascular disorders. Growing geriatric population coupled with rising sedentary lifestyle and unhealthy food habits are anticipated to stimulate the market growth. According to the World Health Organization (WHO), global population between the age group, 65 years and above is projected to rise from 7% in 2000 to 16% in 2050. Aging heightens the risk of chronic diseases such as cardiovascular diseases and diabetes. Lipid testing is an important parameter for monitoring variety of chronic diseases including diabetes, asthma, arthritis and other cardiovascular diseases. Increasing prevalence of such diseases is also expected to drive the market growth significantly. As per the statistics released by the WHO, patients affected with diabetes has risen from 108 million (1980) to 422 million (2014). Similarly, the International Diabetes Federation stated that around 425 million patients have diabetes globally. Growing disease incidences is projected to boost the demand for accurate, speedy and user-friendly diagnostic method, hence, driving the market growth.

Application Takeaway

The global Point of Care Lipid testing market is segmented into three levels: applications, instruments, and geography. Application segment is categorized as hyperlipidemia, hypertriglyceridemia, familial hypercholesterolemia, hyperlipoproteinemia, Tangier disease, and others. Hyperlipidemia segment has captured the large share of the total market. As per the Centres for Disease Control and Prevention, more than 78 million people suffer from abnormal cholesterol level in 2012 which is expected to increase in future years. Such facts will boost the use of point of care lipid diagnosis, leading to augment the market growth to great extent. On another hand, hypertriglyceridemia is projected to gain significant market share over the forecast period owing to the development of novel products. The instrument segment is divided into Roche Cobas b 101, Abaxis Piccolo Xpress, Roche Reflotron, Alere Cholestech LDX, Alere Afinion, Samsung LABGEO PT10, and Cardiocheck.

COVID-19 Impact and Recovery Analysis

The novel COVID-19 has put the world on a standstill, affecting major operations, leading to an industrial catastrophe. However, this market is positively affected due to this outbreak. This report presented by AnalystView Market Insights contains a thorough analysis of the pre and post COVID-19 market scenarios. The report includes all the recent development and changes recorded during the COVID-19 outbreak and comprehends the analysis of top performer segments and marginal growth segment in blood culture test sector.

Key Vendor Takeaway

Samsung, Roche Diagnostics, Alere, Abaxis, Inc., and Bio-Rad Laboratories are profiled in the study. Extensive product portfolio and strategic collaborations with small-scale industry participants are considered to be the key strategies of these players. Other market leaders are also aggressively involved in new product development and expansion of distribution channels to capture a larger share of the market. Moreover, the companies are highly inclined toward maintaining competition in the market as well as delivering economic value to customers and satiate unmet demands.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018

Base Year – 2019

Estimated Year – 2020

Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

Table of Contents
for Point of Care (POC) Lipid Diagnostics Market, By Application (Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease), By Instrument (Roche Cobas b 101, Abaxis Piccolo Xpress, Roche Reflotron, Alere Cholestech LDX, and others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast

  • TABLE OF CONTENT

    1. POC LIPID DIAGNOSTICS MARKET OVERVIEW

    1.1. Study Scope

    1.2. Base Year

    1.3. Assumption and Methodology

    2. EXECUTIVE SUMMARY

    2.1. Key Market Facts

    2.2. Geographical Scenario

    2.3. Companies in the Market

    3. POC LIPID DIAGNOSTICS KEY MARKET TRENDS

    3.1. Market Drivers

    3.1.1. Impact Analysis of Market Drivers

    3.2. Market Restraints

    3.2.1. Impact Analysis of Market Restraints

    3.3. Market Opportunities

    3.4. Market Future Trends

    4. POC LIPID DIAGNOSTICS INDUSTRY STUDY

    4.1. Porter’s Analysis

    4.2. Regulatory Framework Analysis

    4.3. Market Attractiveness Analysis

    4.4. Value Chain Analysis

    5. POC LIPID DIAGNOSTICS MARKET LANDSCAPE

    5.1. Market Share Analysis

    6. POC LIPID DIAGNOSTICS MARKET – BY APPLICATION:

    6.1. Overview

    6.2. Hyperlipidemia

    6.2.1. Overview

    6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.3. Hypertriglyceridemia

    6.3.1. Overview

    6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.4. Familial hypercholesterolemia

    6.4.1. Overview

    6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.5. Hyperlipoproteinemia

    6.5.1. Overview

    6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.6. Tangier disease

    6.6.1. Overview

    6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    6.7. Others

    6.7.1. Overview

    6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7. POC LIPID DIAGNOSTICS MARKET – BY INSTRUMENT:

    7.1. Overview

    7.2. Roche Cobas b 101

    7.2.1. Overview

    7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.3. Abaxis Piccolo Xpress

    7.3.1. Overview

    7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.4. Roche Reflotron

    7.4.1. Overview

    7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.5. Alere Cholestech LDX

    7.5.1. Overview

    7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.6. Alere Afinion

    7.6.1. Overview

    7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.7. Samsung LABGEO PT10

    7.7.1. Overview

    7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    7.8. Cardiocheck

    7.8.1. Overview

    7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8. POC LIPID DIAGNOSTICS MARKET– BY GEOGRAPHY

    8.1. Introduction

    8.2. North America

    8.2.1. Overview

    8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.2.3. U.S.

    8.2.3.1. Overview

    8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.2.4. Canada

    8.2.4.1. Overview

    8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3. Europe

    8.3.1. Overview

    8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.3. France

    8.3.3.1. Overview

    8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.4. Germany

    8.3.4.1. Overview

    8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.3.5. Rest of Europe

    8.3.5.1. Overview

    8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4. Asia Pacific (APAC)

    8.4.1. Overview

    8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.3. China

    8.4.3.1. Overview

    8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.4. India

    8.4.4.1. Overview

    8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.4.5. Rest of APAC

    8.4.5.1. Overview

    8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5. Rest of the World

    8.5.1. Overview

    8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5.3. Latin America

    8.5.3.1. Overview

    8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    8.5.4. Middle East and Africa

    8.5.4.1. Overview

    8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

    9. KEY VENDOR ANALYSIS

    9.1. Samsung

    9.1.1. Company Overview

    9.1.2. SWOT Analysis

    9.1.3. Key Developments

    9.2. Roche Diagnostics

    9.2.1. Company Overview

    9.2.2. SWOT Analysis

    9.2.3. Key Developments

    9.3. Alere

    9.3.1. Company Overview

    9.3.2. SWOT Analysis

    9.3.3. Key Developments

    9.4. Abaxis, Inc.

    9.4.1. Company Overview

    9.4.2. SWOT Analysis

    9.4.3. Key Developments

    9.5. Bio-Rad Laboratories

    9.5.1. Company Overview

    9.5.2. SWOT Analysis

    9.5.3. Key Developments

    *Client can request additional company profiling as per specific requirements

    10. 360 DEGREE ANALYSTVIEW

    11. APPENDIX

    11.1. Research Methodology

    11.2. Abbreviations

    11.3. Disclaimer

    11.4. Contact Us

List Of Tables
in Point of Care (POC) Lipid Diagnostics Market, By Application (Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease), By Instrument (Roche Cobas b 101, Abaxis Piccolo Xpress, Roche Reflotron, Alere Cholestech LDX, and others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast

List of Tables

Table 1 List of Acronyms

Table 2 Key Market Facts, 2016 – 2027

Table 3 Market Drivers: Impact Analysis

Table 4 Market Restraint: Impact Analysis

Table 5 Market Opportunity: Impact Analysis

Table 6 PEST Analysis

Table 7 Porter’s Five Forces Analysis

Table 8 Company Market Share Analysis

Table 9 Global POC Lipid Diagnostics Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 – 2027, (US$ Million)

Table 10 POC Lipid Diagnostics Market, by Application, 2016 – 2027 (USD Million)

Table 11 POC Lipid Diagnostics Market, by Instruments, 2016 – 2027 (USD Million)

Table 12 POC Lipid Diagnostics Market, by Geography, 2016 – 2027 (USD Million)

Table 13 North America POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 14 U.S. POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 15 Canada POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 16 Europe POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 17 France POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 18 Germany POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 19 Asia Pacific POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 20 China POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 21 India POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 22 Latin America POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

Table 23 MEA POC Lipid Diagnostics Market, 2016 – 2027 (USD Million)

List Of Figures, Charts and Diagrams
in Point of Care (POC) Lipid Diagnostics Market, By Application (Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease), By Instrument (Roche Cobas b 101, Abaxis Piccolo Xpress, Roche Reflotron, Alere Cholestech LDX, and others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast

List of Figures

Figure 1 Research Methdology

Figure 2 Research Process Flow Chart

Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)

Figure 4 Regulatory Framework Analysis

Figure 5 Value Chain Analysis Analysis

Figure 6 POC Lipid Diagnostics Market, by Application, 2016 – 2027 (USD Million)

Figure 7 POC Lipid Diagnostics Market, by Instrument, 2016 – 2027 (USD Million)

Figure 8 POC Lipid Diagnostics Market, by Geography, 2016 – 2027 (USD Million)

Additional Details

Publisher

AnalystView

Publisher Information

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.



These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.



We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.



We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.



It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Reference

270582 | AV151

Number of Pages

206

Report Format

PDF

AnalystView Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
11 Jul 2016 by Global Data USD $300 More Info
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
15 Apr 2016 by Global Data USD $300 More Info
MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts
MediPoint: Point of Care Diagnostics - Global Analysis and Market ForecastsSummaryPoint-of-care test...
01 Mar 2016 by Global Data USD $5,995 More Info
Point of Care Diagnostics - Current and Future Players
Point of Care Diagnostics - Current and Future PlayersSummaryThe Point-Of-Care (POC) market is very ...
01 Mar 2016 by Global Data USD $3,500 More Info
Point of Care Diagnostics - US Analysis and Market Forecasts
Point of Care Diagnostics - US Analysis and Market ForecastsSummaryThe US Point-Of-Care (POC) diagno...
01 Mar 2016 by Global Data USD $4,450 More Info
Point of Care Diagnostics - 5EU Analysis and Market Forecasts
Point of Care Diagnostics - 5EU Analysis and Market ForecastsSummaryThe Europe Point-Of-Care (POC) d...
01 Mar 2016 by Global Data USD $4,450 More Info
Point of Care Diagnostics - APAC Analysis and Market Forecasts
Point of Care Diagnostics - APAC Analysis and Market ForecastsSummaryThe Asia-Pacific (APAC) Point-O...
01 Mar 2016 by Global Data USD $4,450 More Info
Point of Care Diagnostics - South American Analysis and Market Forecasts
Point of Care Diagnostics - South American Analysis and Market ForecastsSummaryThe South America Poi...
01 Mar 2016 by Global Data USD $4,450 More Info
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
09 Jan 2016 by Global Data USD $300 More Info
Caplin Point Laboratories Ltd (CAPLIPOINT) - Financial and Strategic SWOT Analysis Review
SummaryCaplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures oi...
08 Nov 2015 by Global Data USD $300 More Info

This report is published by AnalystView

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

We aim to be the number one choice for various clients who require credible data to make vital business decisions. We wish to be a trusted and reliable analytics partner to major business organizations.

We understand that critical business decisions can be taken only when verified, authentic information is available. Therefore, our experts work meticulously to provide our clients with the accurate data, so that they need not spend time in verifying it.

It is also our goal to help our clients ignore traditional research methods that require a large amount of capital, manpower, and most important of it all – the time. We know that these factors are precious to a company and always follow the latest research techniques that produce the required result in a short span of time.

Download Free Report Summary PDF

Point of Care (POC) Lipid Diagnostics Market, By Application (Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease), By Instrument (Roche Cobas b 101, Abaxis Piccolo Xpress, Roche Reflotron, Alere Cholestech LDX, and others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast  | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...